Live bacterium B. thetaiotaomicron

Key facts

Active substance
Live bacterium B. thetaiotaomicron
Therapeutic area
Gastroentology-Hepatology
Decision number
P/166/2009
PIP number
Live bacterium B. thetaiotaomicron
Pharmaceutical form(s)
Live Bacteria in an Enteric Coated Capsule
Condition(s) / indication(s)
Treatment of Crohn's disease
Route(s) of administration
Oral use
Contact for public enquiries
4D Pharma Research Ltd
United Kingdom
E-mail: katrina.lawrie@4dpharmaplc.com
Tel. +44 (0)1224 437369
Decision type
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan

Decision

Topics

How useful was this page?

Add your rating